IP Library Granted Patent US 8,883,421
Granted Patent B2
US 8,883,421 · App. 13/383,466 · Granted Nov 11, 2014

Method for reducing adapter-dimer formation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,883,421
App. No.
13/383,466
Granted
Nov 11, 2014
Kind
B2
Abstract

Methods are provided for ligating a 3′ adapter and a 5′ adapter to a target polynucleotide so as to avoid adapter dimer formation. Embodiments of the methods include adding a blocking oligonucleotide after the first ligation in which a 3′ adapter is ligated to the target polynucleotide so that the blocking oligonucleotide is capable of hybridizing to excess 3′ adapter and the ligated 3′ adapter. Subsequently, a 5′ adapter is ligated to the target polynucleotide thus avoiding adapter dimer formation.

Claims (17)

1. A method for ligating a 3′ adapter and a 5′ adapter to a target polynucleotide so as to avoid adapter dimer formation, comprising:

(a) performing a first ligation between a 3′ end adapter and a target polynucleotide to form a first ligation product and excess 3′ adaptor;

(b) adding a blocking oligonucleotide that hybridizes to the first ligation product and the excess 3′ adapter; and

(c) ligating the first ligation product to a 5′ adapter,

wherein hybridization of the blocking oligonucleotide to excess 3′ adapter prevents the excess 3′ adapter from ligating to the 5′ adapter.

2. A method according to claim 1 , wherein the target polynucleotide is an RNA.

3. A method according to claim 1 , wherein the 3′ adapter is a DNA and the 5′ adapter is an RNA.

4. A method according to claim 1 , wherein the blocking oligonucleotide is a DNA.

5. A method according to claim 1 , wherein the blocking oligonucleotide is a primer for at least one of reverse transcription and amplification.

6. A method according to claim 1 , further comprising: sequencing the target polynucleotide.

7. A method according to claim 6 , wherein sequencing is high through put sequencing.

8. A method according to claim 1 , further comprising quantifying the target polynucleotide.

9. A method according to claim 1 , wherein the target polynucleotide is a member of a polynucleotide library.

10. A method according to claim 1 , wherein the target polynucleotide is an RNA derived from a cell, the 3′ adapter is a DNA, the 5′ adapter is an RNA and the oligonucleotide blocker is a DNA having a sequence that is complementary to the 3′ adaptor.

11. A method according to claim 1 , wherein the 3′ adapter contains a barcode for identifying the target RNA.

12. A method according to claim 11 , wherein the barcode is capable of distinguishing a first target RNA or a first set of target RNAs from a second RNA or a second set of target RNAs.

13. A method according to claim 12 , further comprising: performing at least one of cloning, quantifying or sequencing the first target RNA or the first set of RNAs and the second RNA or second set of RNAs.

Assignments (2)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 27, 2023
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065044/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2012
From: MCREYNOLDS, LARRY A.; MUNAFO, DANIELA
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 027519/0450 →